Remove Access Remove Epilepsy Remove Media
article thumbnail

CBD Market Report

Project CBD

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144
article thumbnail

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Cannabis Law Report

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms. Cannatrek Ltd (22 notices, $293,040) and.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Does Cannabis Legalization Look Like in the UK?

Veriheal

Cannabis is easily accessible, and the regulations are loosening up quite a bit. In 2018, the government was confronted by a media storm that has called for them to act. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

article thumbnail

Specialist Doctors Launch Sapphire Medical Clinic, UK’s First Medicinal Cannabis Clinic to Treat Full Range of Health Issues Including Childhood Epilepsy

Cannabis Law Report

But it is important that access to it is delivered in a way that fits in with other treatment options. It has been widely reported in the media that parents with children suffering from intractable epilepsy continue to experience difficulties in securing prescriptions for medical cannabis products containing THC.

article thumbnail

Navigating The Marijuana Legal Landscape: 5 Benefits For Consumers

Cannabis Law Report

Patients in the UK who are suffering from epilepsy, multiple sclerosis, insomnia, chronic pain, anxiety, and other medical conditions can use medical cannabis as an adjunct or alternative treatment. Provides More Accessible And Safer Sources Of Cannabis.

article thumbnail

Can cannabis products be used to increase overall health and well-being?

Leaf Science

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74
article thumbnail

‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners

Cannabis Law Report

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result.